Block, M. S., Clubb, J. H. A., Mäenpää, J., Pakola, S., Quixabeira, D. C. A., Kudling, T., . . . Hemminki, A. The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: The phase 1a PROTA trial. Nature Portfolio.
Chicago Style (17th ed.) CitationBlock, Matthew Stephen, et al. The Oncolytic Adenovirus TILT-123 with Pembrolizumab in Platinum Resistant or Refractory Ovarian Cancer: The Phase 1a PROTA Trial. Nature Portfolio.
MLA (9th ed.) CitationBlock, Matthew Stephen, et al. The Oncolytic Adenovirus TILT-123 with Pembrolizumab in Platinum Resistant or Refractory Ovarian Cancer: The Phase 1a PROTA Trial. Nature Portfolio.
Warning: These citations may not always be 100% accurate.